MAPK1 and depressive disorder: Treatment of mice with the MEK inhibitor PD184161 increases depression-like behavior [13] whereas an increase of ERK/MAPK signaling was found upon treatment with the mood stabilizers lithium [14], [15] and valproic acid [15], [16].